Shmuel Shoham, M.D., Infectious Diseases
SPECIAL OFFER: - Limited Time Only!
(The ad below will not display on your printed page)


Shmuel Shoham, M.D., Infectious Diseases

Dr. Shoham is a faculty member of the Transplant and Oncology Infectious Diseases Program at Johns Hopkins University School of Medicine.


Why LHJ loves him: We worked with Dr. Shoham on our "Truth or Consequences" feature in the October 2010 issue, and during the fact-checking process he took the time to send a note saying what a pleasure it was to work with us. He's not only very knowledgeable and articulate but truly a nice guy!

Medical degree: Thomas Jefferson University, Jefferson Medical College, 1994.

Bio: Dr. Shoham is a member of the Infectious Disease Society of America, the Greater Washington Infectious Diseases Society, the American College of Physicians, the International Society of Human and Animal Mycology, the American Association for the Advancement of Science, and the American Transplant Society. He has received the Edward K. Kass Award for Clinical Excellence from the Mass Infectious Disease Society, and the James A. Curtin Award for Outstanding Clinical Educator from the Washington Hospital Center Department of Medicine. He's also been named one of Washingtonian magazine's Top Doctors.

Dr. Shoham's research interests include the prevention, diagnosis, and treatment of invasive fungal infections in immunocompromised patients, with a focus on translating bench research to clinical use at the patient bedside and in the community. He has served as the principal investigator for numerous federally and commercially sponsored clinical studies. His ongoing work focuses on improving antimicrobial use through development and application of diagnostic techniques and pharmacokinetic analysis, and prevention and treatment of infections in critically ill patients.

As part of his focus on fostering collaboration between clinical and research interests, Dr. Shoham has partnered with colleagues at the National Cancer Institute (NCI) of the National Institutes of Health (NIH), and within the Mycoses Study Group, a national consortium of academic and private researchers studying treatments for invasive fungal infections. The partnerships developed through Dr. Shoham's collaborative work with the NIH have helped establish WHC as a referral center for complex infections and provides patients at WHC with greater access to cutting-edge studies and potential therapies.